Facet Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$404K Buy
772
+296
+62% +$152K 0.01% 287
2026
Q2
$236K Sell
476
-140
-23% -$62K ﹤0.01% 362
2026
Q1
$275K Buy
+616
New +$287K ﹤0.01% 274
2025
Q4
– Sell
-691
Closed -$271K – 305
2025
Q3
$271K Buy
691
+158
+30% +$66K 0.01% 174
2025
Q2
$244K Buy
+533
New +$246K 0.01% 160

Other funds holding VRTX

Facet Wealth's VRTX Position: Q3 2026 in Review

Facet Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 62% in Q3 2026, buying an estimated $152K and bringing the position to 772 shares worth $404K. The position accounts for 0.01% of the portfolio, ranked #287.

Facet Wealth first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Facet Wealth held 772 shares of Vertex Pharmaceuticals worth $404K as of Q3 2026.
  • Facet Wealth bought 296 Vertex Pharmaceuticals shares in Q3 2026, an estimated $152K.
  • Vertex Pharmaceuticals made up 0.01% of Facet Wealth's portfolio in Q3 2026, its #287 holding.
  • Facet Wealth first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Facet Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.